Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study
2011

Genital warts and HIV infection in high-risk women in Burkina Faso

Sample size: 765 publication 10 minutes Evidence: high

Author Information

Author(s): Andrea J Low, Tim Clayton, Issouf Konate, Nicolas Nagot, Abdoulaye Ouedraogo, Charlotte Huet, Marie-Noelle Didelot-Rousseau, Michel Segondy, Philippe Van de Perre, Philippe Mayaud

Primary Institution: London School of Hygiene & Tropical Medicine

Hypothesis

What are the risk factors for genital warts in high-risk women in Burkina Faso?

Conclusion

Genital warts occur much more frequently among HIV-1 infected women in Africa, especially those with low CD4+ counts.

Supporting Evidence

  • Genital wart prevalence was 1.6% among HIV-uninfected and 7.0% among HIV-1 seropositive women.
  • Incident genital warts were associated with concurrent bacterial vaginosis and genital ulceration.
  • Antiretroviral therapy did not protect against incident or persistent genital warts.

Takeaway

This study found that women with HIV have more genital warts, especially if their immune system is weak.

Methodology

A prospective study of 765 high-risk women followed for 27 months, assessing genital warts and HIV status.

Potential Biases

Potential underreporting of genital warts if women sought treatment elsewhere.

Limitations

The study had varying time between visits and broad anatomical categorizations, which may have led to underestimates of incidence.

Participant Demographics

Women aged 16 years or older, with a history of transactional sex, primarily from Burkina Faso.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 1.97 to 14.40

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-11-20

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication